Cargando…

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1

Detalles Bibliográficos
Autores principales:	Li, Hong-Lin, Sun, Jun-Jie, Ma, Hui, Liu, Shen-Jia, Li, Na, Guo, Su-Jie, Shi, Yang, Xu, Yan-Ying, Qi, Zhi-Ying, Wang, Yu-Quan, Wang, Fang, Guo, Rui-Meng, Liu, Dong, Xue, Feng-Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502922/ https://www.ncbi.nlm.nih.gov/pubmed/37720668 http://dx.doi.org/10.3892/ol.2023.14032

Ejemplares similares

Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]
por: Wang, Wei-Wei, et al.
Publicado: (2020)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”
por: Li, Xiao, et al.
Publicado: (2018)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

Corrigendum to ‘microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma’
por: Su, Wenru, et al.
Publicado: (2023)

Corrigendum to “Six-Year Outcomes of 25-Gauge Chandelier Illumination-Assisted Scleral Buckling”
por: Li, Hui, et al.
Publicado: (2022)

Corrigendum to “Nucleolin interacts with the rabbit hemorrhagic disease virus replicase RdRp, nonstructural proteins p16 and p23, playing a role in virus replication”<[Virologica Sinica 37 (2022) 48–59]>
por: Zhu, Jie, et al.
Publicado: (2023)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Corrigendum to “A Review of Collagen Cross-Linking in Cornea and Sclera”
por: Zhang, Xiao, et al.
Publicado: (2016)

Corrigendum to “FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice”
por: Zhang, Rui, et al.
Publicado: (2020)

Corrigendum to “Positive Effect of Electro-Acupuncture Treatment on Gut Motility in Constipated Mice Is Related to Rebalancing the Gut Microbiota”
por: Xu, Mingmin, et al.
Publicado: (2021)

[Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2
por: Cheng, Yuan, et al.
Publicado: (2023)

Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
por: Zhou, Zhenyu, et al.
Publicado: (2021)

Corrigendum to “Desflurane Attenuates Ventilator-Induced Lung Injury in Rats with Acute Respiratory Distress Syndrome”
por: Lin, Xue, et al.
Publicado: (2021)

Corrigendum: MR‐guided 125I seed implantation treatment for maxillofacial malignant tumor
por: Wang, Ying, et al.
Publicado: (2021)

[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells
por: Zhang, Wenqing, et al.
Publicado: (2023)

Corrigendum to “Plant MicroRNA Prediction by Supervised Machine Learning Using C5.0 Decision Trees”
por: Williams, Philip H., et al.
Publicado: (2017)

Corrigendum to “Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma”
por: Dong, Shuling, et al.
Publicado: (2017)

Corrigendum to: microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus
Publicado: (2023)

Corrigendum to “Wingless-Type MMTV Integration Site Family Member 5a Is a Key Secreted Islet Stellate Cell-Derived Product that Regulates Islet Function”
por: Xu, Wei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2019)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2021)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023)

Corrigendum to “The Effect of Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human Dermal Fibroblasts”
por: Miao, Ying-Ying, et al.
Publicado: (2019)

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2022)

Corrigendum to “Comparative analysis of Phytophthora genomes reveals oomycete pathogenesis in crops” [Heliyon 7 (2) (February 2021) e06317]
por: Gao, Rui-Fang, et al.
Publicado: (2021)

Corrigendum to “Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding”
por: Giannella, Luca, et al.
Publicado: (2020)

Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis
por: Wang, Zihao, et al.
Publicado: (2021)

Corrigendum to “Biologically modified implantation as therapeutic bioabsorbable materials for bone defect repair” [Regen Ther 19 (2022) 9–23]
por: Li, Chao, et al.
Publicado: (2023)

Corrigendum to “Effect of Narrow-Band Ultraviolet B Phototherapy and Methotrexate on MicroRNA (146a) Levels in Blood of Psoriatic Patients”
por: Abou El-Fadle, Amal, et al.
Publicado: (2016)

Corrigendum for The clinicopathological and microRNA expression signature associated with lymphovascular invasion in squamous cell carcinoma: a basic descriptive study
Publicado: (2022)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
por: Sun, Zhiwei, et al.
Publicado: (2021)

[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023)

MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oj3j3mobdmefucbafnl41tc2qo